ResMed | RMD - 贸易债权人

金融业

USD

USD 8.97B

现金及等价物

USD 1.47B

USD 612.93M

USD 4.32B

USD 1.4B

USD 843.17M

股息收益率

0.28

USD 454.34M

USD 559.78M

10.6K

EPS每股收益

USD 2.95

股本和储备

USD 6.59B

USD 861.22M

债务利息支出

USD 8.79M

USD 59K

USD 399.42M

USD 33.2B

USD 383.43M

USD 1.01B

USD 454.34M

普通股股本

USD 145.06M

18.29

USD 502.31M

USD 1.46B

销售和管理费用

USD 290.66M

USD 945.81M

贸易债权人

USD 308.92M

应收帐款人

USD 1.04B

	贸易债权人	更改		日
Ansell	USD 302.3M		51.4M	2025-12
Artivion	USD 20.87M		2.53M	2026-06
AtriCure	USD 78.74M		8.68M	2026-06
Baxter International	USD 1.03B		52M	2026-06
Cochlear	AUD 281.3M		17.1M	2025-12
Cooper Companies	USD 233.3M		7.5M	2026-03
CSL	USD 3.17B		290M	2025-12
Dexcom	USD 2.08B		134.8M	2026-06
Edwards Lifesciences	USD 210.5M		29.4M	2026-06
Fisher Paykel Healthcare	NZD 300.1M		32.3M	2026-06
Globus Medical	USD 106.94M		3.28M	2026-06
Haemonetics	USD 56.34M		5.28M	2026-06
Idexx Laboratories	USD 129.1M		877K	2026-06
Inogen	USD 21.22M		684K	2025-09
Insulet	USD 123.3M		26.5M	2026-06
Integra LifeSciences	USD 82.64M		5.31M	2026-06
Intuitive Surgical	USD 1.92B		66.6M	2026-06
Medtronic	USD 2.57B		12M	2025-12
Philips	EUR 2.08B		90M	2026-06
Ramsay Health Care	AUD 2.02B		289.9M	2025-12
ResMed	USD 308.92M		35.62M	2026-06
Sigma Healthcare	AUD 1.32B		970.03M	2025-12
Sonic Healthcare	AUD 313.54M		543.93M	2024-06
Steris	USD 344.1M		5.3M	2026-06
Teleflex	USD 143.29M		335K	2026-06
Thermo Fisher Scientific	USD 3.34B		278M	2026-03